🔗 Share this article Patients Coming Off Anti-Obesity Jabs Regain Weight Four Times Faster Than Those on Conventional Diets Obesity treatment often requires long-term strategies. A recent study indicates that patients who discontinue blockbuster slimming jabs like semaglutide or tirzepatide may regain lost weight much more quickly than those who stop conventional diet and exercise programs. Published data in a prominent health publication shows that while obese individuals can lose a large proportion of their body weight while using the jabs, the weight returns at an average rate of nearly a kilo each month after stopping. "People using such drugs need to be informed of the risk of rapid weight regain when the therapy is stopped," stated researcher Dr. Susan Jebb. That rate of regain means a reversion to starting weight within about a year and a half. Comparing Treatments The research, which examined dozens of studies involving thousands of patients, contrasted the results of the injectable medications with other pills. Scientists emphasize that individuals who shed pounds through dieting usually see a more gradual creep back—approximately 100 grams monthly—after stopping. Explaining the Fast Rebound Experts suggest the mechanism of the injections is key to understanding the amplified rebound. GLP-1 drugs imitate a body's own chemical called glucagon-like peptide-1, which controls hunger. "Long-term administration of the hormone levels several times higher than the body's typical production could lead to the body to generate a reduced amount of its own natural GLP-1, and could reduce sensitivity to its effects," said Dr. Adam Collins, a dietetics researcher. "Discontinuation of this GLP-1 'fix' leads to hunger is unsuppressed, making excessive eating a significant risk." An Ongoing Condition? Medical guidelines recommend the injections for people with obesity-related medical conditions, accompanied by prescribed lifestyle changes. Professionals say that, considering the significant potential of weight regain, the treatment should be considered long-term. This perspective is echoed by drug manufacturers, who note that the findings "underscore the long-term nature of excess weight," comparing it to managing diseases like high blood pressure. User Testimonies Individuals who have come off the jabs explain a sudden resurgence of hunger. "It was like something activating and you become starving," recalled an individual. This challenge is exacerbated if users have not developed permanent lifestyle or habit changes during treatment. Widespread Use Survey data indicate that a significant number of adults in the UK have tried these injections in the past year, with desire remaining high. Use is greater among females compared to men. The middle-aged demographic shows the greatest usage rates. Many obtain the medications through private prescriptions rather than the NHS. In conclusion, experts stress that while GLP-1 drugs are powerful agents for shedding pounds, they are not a standalone cure and maintained weight loss relies on integrated lifestyle support.
Obesity treatment often requires long-term strategies. A recent study indicates that patients who discontinue blockbuster slimming jabs like semaglutide or tirzepatide may regain lost weight much more quickly than those who stop conventional diet and exercise programs. Published data in a prominent health publication shows that while obese individuals can lose a large proportion of their body weight while using the jabs, the weight returns at an average rate of nearly a kilo each month after stopping. "People using such drugs need to be informed of the risk of rapid weight regain when the therapy is stopped," stated researcher Dr. Susan Jebb. That rate of regain means a reversion to starting weight within about a year and a half. Comparing Treatments The research, which examined dozens of studies involving thousands of patients, contrasted the results of the injectable medications with other pills. Scientists emphasize that individuals who shed pounds through dieting usually see a more gradual creep back—approximately 100 grams monthly—after stopping. Explaining the Fast Rebound Experts suggest the mechanism of the injections is key to understanding the amplified rebound. GLP-1 drugs imitate a body's own chemical called glucagon-like peptide-1, which controls hunger. "Long-term administration of the hormone levels several times higher than the body's typical production could lead to the body to generate a reduced amount of its own natural GLP-1, and could reduce sensitivity to its effects," said Dr. Adam Collins, a dietetics researcher. "Discontinuation of this GLP-1 'fix' leads to hunger is unsuppressed, making excessive eating a significant risk." An Ongoing Condition? Medical guidelines recommend the injections for people with obesity-related medical conditions, accompanied by prescribed lifestyle changes. Professionals say that, considering the significant potential of weight regain, the treatment should be considered long-term. This perspective is echoed by drug manufacturers, who note that the findings "underscore the long-term nature of excess weight," comparing it to managing diseases like high blood pressure. User Testimonies Individuals who have come off the jabs explain a sudden resurgence of hunger. "It was like something activating and you become starving," recalled an individual. This challenge is exacerbated if users have not developed permanent lifestyle or habit changes during treatment. Widespread Use Survey data indicate that a significant number of adults in the UK have tried these injections in the past year, with desire remaining high. Use is greater among females compared to men. The middle-aged demographic shows the greatest usage rates. Many obtain the medications through private prescriptions rather than the NHS. In conclusion, experts stress that while GLP-1 drugs are powerful agents for shedding pounds, they are not a standalone cure and maintained weight loss relies on integrated lifestyle support.